We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Abitare In Spa | BIT:ABT | Italy | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.15 | 3.41% | 4.55 | 4.39 | 4.55 | 4.55 | 4.31 | 4.49 | 30,526 | 17:00:00 |
From Feb 2020 to Feb 2025
The U.S. Food and Drug Administration on Monday said it is investigating whether certain medical device power cords are defective, after receiving more than 100 reports of power cord failures from Abbott Laboratories (ABT) and Hospira Inc. (HSP).
The companies have sent the FDA 122 reports of "sparking, charring, and fires" from power cords used with their devices, according to a posting on the FDA's Web site.
The FDA said failures with power cords can lead to serious complications, including death.
The agency said the cords were all made by Electri-cord Manufacturing Co., based in Pennsylvania.
Hospira in August said it was recalling certain devices with the power cords. The company said the cords' prongs may crack and fail at or inside the plug. Electri-cord Manufacturing said at the time that it puts all its products through extensive testing.
-By Jared A. Favole, Dow Jones Newswires; 202.862.9207; jared.favole@dowjones.com
1 Year Abitare In Chart |
1 Month Abitare In Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
